But while voters are consistently backing abortion rights in referendums, they aren’t always choosing the Democrats who ...

At the moment, there’s just not enough data to understand what’s happened to the tens of thousands of missing cancer cases, ...

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age.

The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, ...

A study focused on how hospital websites promote LGBTQ+ services or policies produced "very concerning" results, one of its ...

Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But ...

The average age of an occupational and environmental medicine physician is 63. Yet more than half of training sites have ...

The Broad Institute of MIT and Harvard, one of the most prominent biotech research centers in the world, has laid off 87 ...

SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread ...

The race to supply obesity drugs is so competitive that one startup is already striking a deal for commercial manufacturing even when its lead candidate is still in early stage testing. Metsera, a ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...